Abstract
Animal models of diseases are essential for drug discovery and development. The availability of a large number of genetically-manipulated mice renders considerable interest in drug discovery by means of experimental models of disease. Ferric chloride-induced thrombosis is one of the most commonly used experimental models of thrombosis in mice. This review provides examples of optimizing this arterial thrombosis model for target validation and drug discovery in mice.
Keywords: animal model, drug discovery, hemostasis, thrombosis, mouse
Letters in Drug Design & Discovery
Title: Experimental Mouse Models of Thrombosis Optimized for Drug Discovery and Development
Volume: 2 Issue: 5
Author(s): X. Wang
Affiliation:
Keywords: animal model, drug discovery, hemostasis, thrombosis, mouse
Abstract: Animal models of diseases are essential for drug discovery and development. The availability of a large number of genetically-manipulated mice renders considerable interest in drug discovery by means of experimental models of disease. Ferric chloride-induced thrombosis is one of the most commonly used experimental models of thrombosis in mice. This review provides examples of optimizing this arterial thrombosis model for target validation and drug discovery in mice.
Export Options
About this article
Cite this article as:
Wang X., Experimental Mouse Models of Thrombosis Optimized for Drug Discovery and Development, Letters in Drug Design & Discovery 2005; 2 (5) . https://dx.doi.org/10.2174/1570180054405785
DOI https://dx.doi.org/10.2174/1570180054405785 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers